Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for Cognitive Recovery and White Matter Growth in Paediatric Patients With a Brain Tumour
NCT05230758Phase 3Recruiting
- Start
- Jul 2022
- Primary completion
- Nov 2027
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of liquid metformin (Aspargo Labs) in cognitive impairment. Started Jul 2022; status: recruiting.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT05230758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05230758.